Literature DB >> 9077119

The subcellular localization of Zn(II) phthalocyanines and their redistribution on exposure to light.

S R Wood1, J A Holroyd, S B Brown.   

Abstract

The development of second-generation photosensitizers to improve photodynamic therapy (PDT) is an area of extensive research. Three such compounds that have been synthesized in our group are polysubstituted Zn(II) phthalocyanines that differ in their overall net charge (one cationic, one anionic and one neutral). The aim of this study was to characterize the drugs in terms of their uptake, cell killing efficacy and subcellular localization in RIF-1 cells in vitro and to identify any possible structure/function relationships. The results show that the relative uptakes and cell killing efficacy of each of the drugs follows the order cationic > > neutral > anionic. For the anionic and cationic drugs the initial subcellular localization was in the lysosomes as determined by fluorescence microscopy. The neutral phthalocyanine demonstrated a more diffuse localization characteristic of membrane staining with some involvement of the Golgi apparatus in the perinuclear area. Following light exposure the drugs rapidly relocalized to different sites within the cell in a manner that was apparently charge dependent and this relocalization was accompanied by an increase in the fluorescence associated with the drugs. This indicates that the primary sites of localization of these photosensitizers may not be as important as their secondary sites in producing cell killing during PDT, especially as the fluorescence intensity increases on relocalization.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9077119     DOI: 10.1111/j.1751-1097.1997.tb08577.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  8 in total

Review 1.  Structural and physico-chemical determinants of the interactions of macrocyclic photosensitizers with cells.

Authors:  Halina Mojzisova; Stéphanie Bonneau; Daniel Brault
Journal:  Eur Biophys J       Date:  2007-07-13       Impact factor: 1.733

2.  Synthesis and evaluation of cationic bacteriochlorin amphiphiles with effective in vitro photodynamic activity against cancer cells at low nanomolar concentration.

Authors:  Sulbha K Sharma; Michael Krayer; Felipe F Sperandio; Liyi Huang; Ying-Ying Huang; Dewey Holten; Jonathan S Lindsey; Michael R Hamblin
Journal:  J Porphyr Phthalocyanines       Date:  2013-01       Impact factor: 1.811

3.  31P magnetic resonance spectroscopy as a predictor of efficacy in photodynamic therapy using differently charged zinc phthalocyanines.

Authors:  J C Bremner; S R Wood; J K Bradley; J Griffiths; G E Adams; S B Brown
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

Review 4.  Enhancing Breast Cancer Treatment Using a Combination of Cannabidiol and Gold Nanoparticles for Photodynamic Therapy.

Authors:  Dimakatso R Mokoena; Blassan P George; Heidi Abrahamse
Journal:  Int J Mol Sci       Date:  2019-09-26       Impact factor: 5.923

Review 5.  Cell death pathways and phthalocyanine as an efficient agent for photodynamic cancer therapy.

Authors:  Ivan Mfouo-Tynga; Heidi Abrahamse
Journal:  Int J Mol Sci       Date:  2015-05-06       Impact factor: 5.923

6.  Zinc Phthalocyanine Photochemistry by Raman Imaging, Fluorescence Spectroscopy and Femtosecond Spectroscopy in Normal and Cancerous Human Colon Tissues and Single Cells.

Authors:  Beata Brozek-Pluska; Arkadiusz Jarota; Rafal Kania; Halina Abramczyk
Journal:  Molecules       Date:  2020-06-10       Impact factor: 4.411

Review 7.  Photoimmunotherapy of Ovarian Cancer: A Unique Niche in the Management of Advanced Disease.

Authors:  Shubhankar Nath; Mohammad Ahsan Saad; Michael Pigula; Joseph W R Swain; Tayyaba Hasan
Journal:  Cancers (Basel)       Date:  2019-11-27       Impact factor: 6.639

Review 8.  Role of Photoactive Phytocompounds in Photodynamic Therapy of Cancer.

Authors:  Kasipandi Muniyandi; Blassan George; Thangaraj Parimelazhagan; Heidi Abrahamse
Journal:  Molecules       Date:  2020-09-08       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.